Salience Clinical White Paper Series
Psilocybin at a Regulatory Crossroads: Five Unresolved Questions Shaping the Future of Psychedelic Medicine Denis Katz, MD Founder & Medical Director, Salience Clinical LLC Introduction The optimism surrounding psilocybin is not unfounded. Early clinical findings have been striking enough to attract serious scientific attention, substantial investment, and a level of public interest that...
0 Yorumlar 0 Paylaşım 16 Görüş 0 Yorumlar
Fodsu Sosyal medya https://fodsu.com